Back

Low-dose mineralocorticoid receptor antagonists improve outcomes without dose escalation in elderly TEER patients with systolic heart failure

1 September 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (4) - Interventions for structural disease and stroke Mitral Valve Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Teruhiko Imamura

University of Toyama, Toyama (Japan)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor C. Nakai (Albany, US)
Abstract Slides Video
Presentation thumbnail
Doctor A. Apostolos (London, GB)
Abstract Slides Video
Presentation thumbnail
Doctor A. Reina (Seville, ES)
Abstract
Presentation thumbnail
Doctor N. Ktenopoulos (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (4) - Interventions for structural disease and stroke

The Event

Event poster

ESC Congress 2025

1 September 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Outcomes of transcatheter edge-to-edge repair for moderate mitral regurgitation
28 August 2026
thumbnail
Congress Presentation
Barriers and pre-concepts to the use of MRAs
12 May 2024
thumbnail
Congress Presentation
Mineralocorticoid receptor antagonists therapy in transthyretin amyloid cardiomyopathy: a propensity-matched cohort study
9 May 2026
thumbnail
Congress Presentation
Incremental benefit of sodium–glucose cotransporter 2 inhibitor and mineralocorticoid receptor antagonist therapy in HFpEF with moderate mitral regurgitation: 24-month ambulatory cohort study
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources